IRODALOM:
1. Annibale,B., D’Ambra,G., Marignani,M. et al.: Acid secretion was not reduced by H. pylori (Hp) eradication in hypersecretory duodenal ulcer (HDU) and antral G cell hyperplasia (AGCH) patients.
Gastroenterology 1998,114,A57
2. Savarino,V., Mela,G.S., Zentilin,P et al.: 24-hour gastric pH and duodenal
gastric metaplasia one year after eradication of Helicobacter pylori nfection in duodenal ulcer patients
Gastroenterology, 1998,114,A278
3. I.Rácz, A.Szabó, Gy.Pécsi, M.Csöndes, Á.Erényi, M.Goda: Gastric metaplasia, acid secretion and duodenal Helicobacter pylori colonization in uodenal ulcer patients
Gut, 1998,43,A61
4. Bretagne,J.F., Caekaert,A., Bartheleny,P. et al.: The course of symptoms atter eradication of Helicobacter pylori: A one-year follow-up of a cohort of 58 patients with duodenal ulcer or nonulcer dyspepsia.
Gastroenterology, 1998,114,A80
5. Bretagne,J.F., Bartheleny,P., Caekaert,A. et al.: Gastroesophageal reflux disease (GERD) and peptic esophagitis (PE) a complication of the eradication of Helicobacter (H.p.) in patients with, duodenal ulcer?
Gastroenterology, 1998,114,A80
pylori
6. DiMario,F., Dal Bo,N., Salandin,S. et al.: The appearance of GORD in patients with duodenal ulcer after eradication of Helicobacter pylori (Hp.) infection: a 4 year prospective study.
Gastroenterology, 1998,114, A105
7. Talley,H.J., Jannsens,J., Lauritsen,K. et al.: No increase of reflux symptoms in patients with non-ulcer dyspepsia 12 months after Helicobacter pylori eradication. A
randomized double-blind placebo controlled trial. Digestion 1998, 59(Suppl. 3),7
8. McColl,K., Murray,L., El-Omar,E. et al.: Symptomatic benefit from eradicating Helicobacter pylori infection in patients with non-ulcer dyspepsia.
N. Engl.J.Med. 1998,339, 1869-74
9. Talley,N,J., Janssens,J., Lauritsen,K. et al.: H. pylori eradication therapy for non-ulcer dyspepsia. A randomized double-blind placebo-controlled long term trial.
Gut 1998,43 (Suppl.2) A3
10. Chan,F.K.L., Sung,J.Y., Sydney Chung,S.C. et al.: Randomised trial of eradication of
Helicobacter pylori before non-steroidal antiinflammatory drug therapy to prevent peptic ulcer.
9
Gyomor – gastroenterologia – Rácz István
Lancet 1997,350,975-79
11. Chan,F.K.L., Sung,J.Y., Suen,R. et al.: Eradication of H. pylori prevents recurrent gastroduodenal hemorrhage in high risk aspirin but not non-aspirin NSAID users.
Gut 1998,43 (Suppl.2) A3
12. Hawkey,C.J., Tulassay,Z., Szczepanski,L. et al.: Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal antiinflammatory drugs: HELP NSAIDs study
Lancet 1998, 352,1016-21
13. Chan,F.K.L., Sung J.J.Y., Suen,R. et al.: Does eradication of Helicobacter pylori impair healing of nonsteroidal antiinflammatory drug associated bleeding peptic ulcers? A prospective randomized study.
Aliment. Pharmacol Ther. 1998,12,1201-05
14. Cutler,A.F., Elnagger,M., Brooks,E., et al.: Effect of standard and high dose ranitidine on 13C-urea breath test results.
Am.J. of Gastroenterology 1998,93,1297-99
15. Alm,R.A., Ling,L-S., L., Moir,D.T. et al.: Genomic-sequence comparison of two
unrelated isolates of the human gastric pathogen Helicobacter pylori
Nature 1999, 397, 176-180
16. O’ Connor,H.J., Mc Longhlin,R., Kelly,S. et al.: Lansoprazole triple therapy for Helicobacter pylori – is 5 days enongh?
Aliment. Pharmacol. Ther. 1998,12,273-276
17. Trevisani,L., Sartori,S., Caselli,M., et al.: A four-day low dose triple therapy regimen for the treatment of Helicobacter pylori infection
Am.J. of Hgastroenterology 1998,93,390-393
18. Megraud,F.: Epidemiology and Mechanisms of antibiotic resistance in Helicobacter pylori.
Gastroenterology 1998,115,1278-1282
19. Graham,D.Y.: Antibiotic resistance in Helicobacter pylori. Implications for therapy. Gastroenterology 1998,115,1272-1277
20. van Zwet,A.A., Vandenbrouke-Grauls,C.M.J.E., Thijs,J.C., et al.: Stable amoxicillin
resistance in Helicobacter pylori
Lancet 1998,352,1595
21. Folsom,A.R., Nieto,F.J., Sorlie,P. et al.: Helicobacter pylori seropositivity and coronary heart disease
Circulation 1998,98,845-850
10
Gyomor – gastroenterologia – Rácz István
22. Fisher,R.S., Kushner,M., Bonapace,E. et al.: Rebound acid hypersecretion after gastric acid suppressant therapy: a short-lived (less than 1 week) phenomenon.
Gastroenterology 1998,114,A13
23. Gillen,D., Wirz,A., Ardill,J.E.S., et al.: Rebound acid hypersecretion with on-treatment intragastric pH and on-treatment plasma gastrin
Gastroenterology 1998,114, A133
24. Bashford,J.N.R., Norwood,J., Chapman,S. et al.: Why are patients prescribed proton pump inhibitors? Retrospective analysis of link between morbitdity and prescribing in the General Practice Research Database
BMJ 1998,317,452-456
25. Yeomans,N.D., Tulassay,Z., Juhász,L. et al.: A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs.
N.Engl.J.Med. 1998,338,719-726
